Pyridine compounds for the treatment of prostaglandin mediated diseases
US7759369B2 · kind B2 · utility
0Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2007 |
| Grant date | Jul 20, 2010 |
| Priority date | — |
| Expiry date | Dec 23, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) or a pharmaceutically acceptable derivative thereof:wherein X, Y, Z, R2a, R2b, R3a, R3b, R8, R9, and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.